Global Influenza Drugs Market Research Report 2025(Status and Outlook)

March 2025 | 171 pages | ID: G98D49B97FE8EN
Bosson Research

Abstracts

Report Overview

Influenza drugs refer to pharmaceutical products designed to prevent, treat, or alleviate symptoms associated with influenza, a highly contagious respiratory illness caused by influenza viruses. These drugs include antiviral medications such as oseltamivir (Tamiflu) and zanamivir (Relenza), which are commonly used to reduce the severity and duration of influenza symptoms. In addition, influenza vaccines are also considered a key component of influenza drug therapy, aimed at preventing infection and reducing the spread of the virus within communities. The market for influenza drugs encompasses a wide range of products targeting different aspects of the disease, from prevention to treatment, and plays a crucial role in public health strategies to combat seasonal influenza outbreaks.

The market for influenza drugs is influenced by several key trends and market drivers. One significant trend is the increasing prevalence of influenza outbreaks worldwide, leading to a growing demand for effective treatment and prevention options. In addition, advancements in medical research and technology have resulted in the development of new and improved influenza drugs with enhanced efficacy and safety profiles. Moreover, government initiatives and public awareness campaigns promoting influenza vaccination and antiviral treatment have further fueled market growth. At the same time, factors such as changing climatic conditions, globalization, and the emergence of new influenza virus strains contribute to the dynamic nature of the influenza drug market, driving innovation and competition among pharmaceutical companies in this sector.

This report provides a deep insight into the global Influenza Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Influenza Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Influenza Drugs market in any manner.

Global Influenza Drugs Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Bristol-Myers Squibb]

AstraZeneca

Eli Lilly

Roche

GlaxoSmithKline

Novartis

Pfizer

Sanofi Pasteur

Bayer

Celgene

Seqirus

Protein Sciences Corporation

Serum Institute of India

Emergent Biosolutions

BioCryst Pharmaceuticals

Alvogen

Market Segmentation (by Type)

Zanamivir

Oseltamivir Phosphate

Peramivir

Other Influenza Drugs

Market Segmentation (by Application)

Adults

Chidren

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Influenza Drugs Market
• Overview of the regional outlook of the Influenza Drugs Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Influenza Drugs Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Influenza Drugs
1.2 Key Market Segments
1.2.1 Influenza Drugs Segment by Type
1.2.2 Influenza Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Influenza Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global Influenza Drugs Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Influenza Drugs Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Influenza Drugs Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Influenza Drugs Product Life Cycle
3.3 Global Influenza Drugs Sales by Manufacturers (2020-2025)
3.4 Global Influenza Drugs Revenue Market Share by Manufacturers (2020-2025)
3.5 Influenza Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Influenza Drugs Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Influenza Drugs Manufacturing Sites, Area Served, Product Type
3.8 Influenza Drugs Market Competitive Situation and Trends
3.8.1 Influenza Drugs Market Concentration Rate
3.8.2 Global 5 and 10 Largest Influenza Drugs Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Influenza Drugs Industry Chain Analysis
4.1 Influenza Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Influenza Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Influenza Drugs Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Influenza Drugs Market
5.7 ESG Ratings of Leading Companies
6 Influenza Drugs Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Influenza Drugs Sales Market Share by Type (2020-2025)
6.3 Global Influenza Drugs Market Size Market Share by Type (2020-2025)
6.4 Global Influenza Drugs Price by Type (2020-2025)
7 Influenza Drugs Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Influenza Drugs Market Sales by Application (2020-2025)
7.3 Global Influenza Drugs Market Size (M USD) by Application (2020-2025)
7.4 Global Influenza Drugs Sales Growth Rate by Application (2020-2025)
8 Influenza Drugs Market Sales by Region
8.1 Global Influenza Drugs Sales by Region
8.1.1 Global Influenza Drugs Sales by Region
8.1.2 Global Influenza Drugs Sales Market Share by Region
8.2 Global Influenza Drugs Market Size by Region
8.2.1 Global Influenza Drugs Market Size by Region
8.2.2 Global Influenza Drugs Market Size Market Share by Region
8.3 North America
8.3.1 North America Influenza Drugs Sales by Country
8.3.2 North America Influenza Drugs Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Influenza Drugs Sales by Country
8.4.2 Europe Influenza Drugs Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Influenza Drugs Sales by Region
8.5.2 Asia Pacific Influenza Drugs Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Influenza Drugs Sales by Country
8.6.2 South America Influenza Drugs Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Influenza Drugs Sales by Region
8.7.2 Middle East and Africa Influenza Drugs Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 Influenza Drugs Market Production by Region
9.1 Global Production of Influenza Drugs by Region(2020-2025)
9.2 Global Influenza Drugs Revenue Market Share by Region (2020-2025)
9.3 Global Influenza Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Influenza Drugs Production
9.4.1 North America Influenza Drugs Production Growth Rate (2020-2025)
9.4.2 North America Influenza Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Influenza Drugs Production
9.5.1 Europe Influenza Drugs Production Growth Rate (2020-2025)
9.5.2 Europe Influenza Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Influenza Drugs Production (2020-2025)
9.6.1 Japan Influenza Drugs Production Growth Rate (2020-2025)
9.6.2 Japan Influenza Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Influenza Drugs Production (2020-2025)
9.7.1 China Influenza Drugs Production Growth Rate (2020-2025)
9.7.2 China Influenza Drugs Production, Revenue, Price and Gross Margin (2020-2025)
10 Key Companies Profile
10.1 Bristol-Myers Squibb]
10.1.1 Bristol-Myers Squibb] Basic Information
10.1.2 Bristol-Myers Squibb] Influenza Drugs Product Overview
10.1.3 Bristol-Myers Squibb] Influenza Drugs Product Market Performance
10.1.4 Bristol-Myers Squibb] Business Overview
10.1.5 Bristol-Myers Squibb] SWOT Analysis
10.1.6 Bristol-Myers Squibb] Recent Developments
10.2 AstraZeneca
10.2.1 AstraZeneca Basic Information
10.2.2 AstraZeneca Influenza Drugs Product Overview
10.2.3 AstraZeneca Influenza Drugs Product Market Performance
10.2.4 AstraZeneca Business Overview
10.2.5 AstraZeneca SWOT Analysis
10.2.6 AstraZeneca Recent Developments
10.3 Eli Lilly
10.3.1 Eli Lilly Basic Information
10.3.2 Eli Lilly Influenza Drugs Product Overview
10.3.3 Eli Lilly Influenza Drugs Product Market Performance
10.3.4 Eli Lilly Business Overview
10.3.5 Eli Lilly SWOT Analysis
10.3.6 Eli Lilly Recent Developments
10.4 Roche
10.4.1 Roche Basic Information
10.4.2 Roche Influenza Drugs Product Overview
10.4.3 Roche Influenza Drugs Product Market Performance
10.4.4 Roche Business Overview
10.4.5 Roche Recent Developments
10.5 GlaxoSmithKline
10.5.1 GlaxoSmithKline Basic Information
10.5.2 GlaxoSmithKline Influenza Drugs Product Overview
10.5.3 GlaxoSmithKline Influenza Drugs Product Market Performance
10.5.4 GlaxoSmithKline Business Overview
10.5.5 GlaxoSmithKline Recent Developments
10.6 Novartis
10.6.1 Novartis Basic Information
10.6.2 Novartis Influenza Drugs Product Overview
10.6.3 Novartis Influenza Drugs Product Market Performance
10.6.4 Novartis Business Overview
10.6.5 Novartis Recent Developments
10.7 Pfizer
10.7.1 Pfizer Basic Information
10.7.2 Pfizer Influenza Drugs Product Overview
10.7.3 Pfizer Influenza Drugs Product Market Performance
10.7.4 Pfizer Business Overview
10.7.5 Pfizer Recent Developments
10.8 Sanofi Pasteur
10.8.1 Sanofi Pasteur Basic Information
10.8.2 Sanofi Pasteur Influenza Drugs Product Overview
10.8.3 Sanofi Pasteur Influenza Drugs Product Market Performance
10.8.4 Sanofi Pasteur Business Overview
10.8.5 Sanofi Pasteur Recent Developments
10.9 Bayer
10.9.1 Bayer Basic Information
10.9.2 Bayer Influenza Drugs Product Overview
10.9.3 Bayer Influenza Drugs Product Market Performance
10.9.4 Bayer Business Overview
10.9.5 Bayer Recent Developments
10.10 Celgene
10.10.1 Celgene Basic Information
10.10.2 Celgene Influenza Drugs Product Overview
10.10.3 Celgene Influenza Drugs Product Market Performance
10.10.4 Celgene Business Overview
10.10.5 Celgene Recent Developments
10.11 Seqirus
10.11.1 Seqirus Basic Information
10.11.2 Seqirus Influenza Drugs Product Overview
10.11.3 Seqirus Influenza Drugs Product Market Performance
10.11.4 Seqirus Business Overview
10.11.5 Seqirus Recent Developments
10.12 Protein Sciences Corporation
10.12.1 Protein Sciences Corporation Basic Information
10.12.2 Protein Sciences Corporation Influenza Drugs Product Overview
10.12.3 Protein Sciences Corporation Influenza Drugs Product Market Performance
10.12.4 Protein Sciences Corporation Business Overview
10.12.5 Protein Sciences Corporation Recent Developments
10.13 Serum Institute of India
10.13.1 Serum Institute of India Basic Information
10.13.2 Serum Institute of India Influenza Drugs Product Overview
10.13.3 Serum Institute of India Influenza Drugs Product Market Performance
10.13.4 Serum Institute of India Business Overview
10.13.5 Serum Institute of India Recent Developments
10.14 Emergent Biosolutions
10.14.1 Emergent Biosolutions Basic Information
10.14.2 Emergent Biosolutions Influenza Drugs Product Overview
10.14.3 Emergent Biosolutions Influenza Drugs Product Market Performance
10.14.4 Emergent Biosolutions Business Overview
10.14.5 Emergent Biosolutions Recent Developments
10.15 BioCryst Pharmaceuticals
10.15.1 BioCryst Pharmaceuticals Basic Information
10.15.2 BioCryst Pharmaceuticals Influenza Drugs Product Overview
10.15.3 BioCryst Pharmaceuticals Influenza Drugs Product Market Performance
10.15.4 BioCryst Pharmaceuticals Business Overview
10.15.5 BioCryst Pharmaceuticals Recent Developments
10.16 Alvogen
10.16.1 Alvogen Basic Information
10.16.2 Alvogen Influenza Drugs Product Overview
10.16.3 Alvogen Influenza Drugs Product Market Performance
10.16.4 Alvogen Business Overview
10.16.5 Alvogen Recent Developments
11 Influenza Drugs Market Forecast by Region
11.1 Global Influenza Drugs Market Size Forecast
11.2 Global Influenza Drugs Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Influenza Drugs Market Size Forecast by Country
11.2.3 Asia Pacific Influenza Drugs Market Size Forecast by Region
11.2.4 South America Influenza Drugs Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Influenza Drugs by Country
12 Forecast Market by Type and by Application (2026-2033)
12.1 Global Influenza Drugs Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Influenza Drugs by Type (2026-2033)
12.1.2 Global Influenza Drugs Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Influenza Drugs by Type (2026-2033)
12.2 Global Influenza Drugs Market Forecast by Application (2026-2033)
12.2.1 Global Influenza Drugs Sales (K MT) Forecast by Application
12.2.2 Global Influenza Drugs Market Size (M USD) Forecast by Application (2026-2033)
13 Conclusion and Key FindingsList of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Influenza Drugs Market Size Comparison by Region (M USD)
Table 5. Global Influenza Drugs Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Influenza Drugs Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Influenza Drugs Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Influenza Drugs Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Drugs as of 2024)
Table 10. Global Market Influenza Drugs Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 11. Manufacturers Influenza Drugs Manufacturing Sites and Area Served
Table 12. Manufacturers Influenza Drugs Product Type
Table 13. Global Influenza Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Influenza Drugs Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. Global Influenza Drugs Sales by Type (K MT)
Table 25. Global Influenza Drugs Market Size by Type (M USD)
Table 26. Global Influenza Drugs Sales (K MT) by Type (2020-2025)
Table 27. Global Influenza Drugs Sales Market Share by Type (2020-2025)
Table 28. Global Influenza Drugs Market Size (M USD) by Type (2020-2025)
Table 29. Global Influenza Drugs Market Size Share by Type (2020-2025)
Table 30. Global Influenza Drugs Price (USD/MT) by Type (2020-2025)
Table 31. Global Influenza Drugs Sales (K MT) by Application
Table 32. Global Influenza Drugs Market Size by Application
Table 33. Global Influenza Drugs Sales by Application (2020-2025) & (K MT)
Table 34. Global Influenza Drugs Sales Market Share by Application (2020-2025)
Table 35. Global Influenza Drugs Market Size by Application (2020-2025) & (M USD)
Table 36. Global Influenza Drugs Market Share by Application (2020-2025)
Table 37. Global Influenza Drugs Sales Growth Rate by Application (2020-2025)
Table 38. Global Influenza Drugs Sales by Region (2020-2025) & (K MT)
Table 39. Global Influenza Drugs Sales Market Share by Region (2020-2025)
Table 40. Global Influenza Drugs Market Size by Region (2020-2025) & (M USD)
Table 41. Global Influenza Drugs Market Size Market Share by Region (2020-2025)
Table 42. North America Influenza Drugs Sales by Country (2020-2025) & (K MT)
Table 43. North America Influenza Drugs Market Size by Country (2020-2025) & (M USD)
Table 44. Europe Influenza Drugs Sales by Country (2020-2025) & (K MT)
Table 45. Europe Influenza Drugs Market Size by Country (2020-2025) & (M USD)
Table 46. Asia Pacific Influenza Drugs Sales by Region (2020-2025) & (K MT)
Table 47. Asia Pacific Influenza Drugs Market Size by Region (2020-2025) & (M USD)
Table 48. South America Influenza Drugs Sales by Country (2020-2025) & (K MT)
Table 49. South America Influenza Drugs Market Size by Country (2020-2025) & (M USD)
Table 50. Middle East and Africa Influenza Drugs Sales by Region (2020-2025) & (K MT)
Table 51. Middle East and Africa Influenza Drugs Market Size by Region (2020-2025) & (M USD)
Table 52. Global Influenza Drugs Production (K MT) by Region(2020-2025)
Table 53. Global Influenza Drugs Revenue (US$ Million) by Region (2020-2025)
Table 54. Global Influenza Drugs Revenue Market Share by Region (2020-2025)
Table 55. Global Influenza Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 56. North America Influenza Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 57. Europe Influenza Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 58. Japan Influenza Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 59. China Influenza Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 60. Bristol-Myers Squibb] Basic Information
Table 61. Bristol-Myers Squibb] Influenza Drugs Product Overview
Table 62. Bristol-Myers Squibb] Influenza Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 63. Bristol-Myers Squibb] Business Overview
Table 64. Bristol-Myers Squibb] SWOT Analysis
Table 65. Bristol-Myers Squibb] Recent Developments
Table 66. AstraZeneca Basic Information
Table 67. AstraZeneca Influenza Drugs Product Overview
Table 68. AstraZeneca Influenza Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 69. AstraZeneca Business Overview
Table 70. AstraZeneca SWOT Analysis
Table 71. AstraZeneca Recent Developments
Table 72. Eli Lilly Basic Information
Table 73. Eli Lilly Influenza Drugs Product Overview
Table 74. Eli Lilly Influenza Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. Eli Lilly Business Overview
Table 76. Eli Lilly SWOT Analysis
Table 77. Eli Lilly Recent Developments
Table 78. Roche Basic Information
Table 79. Roche Influenza Drugs Product Overview
Table 80. Roche Influenza Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 81. Roche Business Overview
Table 82. Roche Recent Developments
Table 83. GlaxoSmithKline Basic Information
Table 84. GlaxoSmithKline Influenza Drugs Product Overview
Table 85. GlaxoSmithKline Influenza Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. GlaxoSmithKline Business Overview
Table 87. GlaxoSmithKline Recent Developments
Table 88. Novartis Basic Information
Table 89. Novartis Influenza Drugs Product Overview
Table 90. Novartis Influenza Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 91. Novartis Business Overview
Table 92. Novartis Recent Developments
Table 93. Pfizer Basic Information
Table 94. Pfizer Influenza Drugs Product Overview
Table 95. Pfizer Influenza Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 96. Pfizer Business Overview
Table 97. Pfizer Recent Developments
Table 98. Sanofi Pasteur Basic Information
Table 99. Sanofi Pasteur Influenza Drugs Product Overview
Table 100. Sanofi Pasteur Influenza Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 101. Sanofi Pasteur Business Overview
Table 102. Sanofi Pasteur Recent Developments
Table 103. Bayer Basic Information
Table 104. Bayer Influenza Drugs Product Overview
Table 105. Bayer Influenza Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 106. Bayer Business Overview
Table 107. Bayer Recent Developments
Table 108. Celgene Basic Information
Table 109. Celgene Influenza Drugs Product Overview
Table 110. Celgene Influenza Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 111. Celgene Business Overview
Table 112. Celgene Recent Developments
Table 113. Seqirus Basic Information
Table 114. Seqirus Influenza Drugs Product Overview
Table 115. Seqirus Influenza Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Seqirus Business Overview
Table 117. Seqirus Recent Developments
Table 118. Protein Sciences Corporation Basic Information
Table 119. Protein Sciences Corporation Influenza Drugs Product Overview
Table 120. Protein Sciences Corporation Influenza Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 121. Protein Sciences Corporation Business Overview
Table 122. Protein Sciences Corporation Recent Developments
Table 123. Serum Institute of India Basic Information
Table 124. Serum Institute of India Influenza Drugs Product Overview
Table 125. Serum Institute of India Influenza Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 126. Serum Institute of India Business Overview
Table 127. Serum Institute of India Recent Developments
Table 128. Emergent Biosolutions Basic Information
Table 129. Emergent Biosolutions Influenza Drugs Product Overview
Table 130. Emergent Biosolutions Influenza Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 131. Emergent Biosolutions Business Overview
Table 132. Emergent Biosolutions Recent Developments
Table 133. BioCryst Pharmaceuticals Basic Information
Table 134. BioCryst Pharmaceuticals Influenza Drugs Product Overview
Table 135. BioCryst Pharmaceuticals Influenza Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 136. BioCryst Pharmaceuticals Business Overview
Table 137. BioCryst Pharmaceuticals Recent Developments
Table 138. Alvogen Basic Information
Table 139. Alvogen Influenza Drugs Product Overview
Table 140. Alvogen Influenza Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 141. Alvogen Business Overview
Table 142. Alvogen Recent Developments
Table 143. Global Influenza Drugs Sales Forecast by Region (2026-2033) & (K MT)
Table 144. Global Influenza Drugs Market Size Forecast by Region (2026-2033) & (M USD)
Table 145. North America Influenza Drugs Sales Forecast by Country (2026-2033) & (K MT)
Table 146. North America Influenza Drugs Market Size Forecast by Country (2026-2033) & (M USD)
Table 147. Europe Influenza Drugs Sales Forecast by Country (2026-2033) & (K MT)
Table 148. Europe Influenza Drugs Market Size Forecast by Country (2026-2033) & (M USD)
Table 149. Asia Pacific Influenza Drugs Sales Forecast by Region (2026-2033) & (K MT)
Table 150. Asia Pacific Influenza Drugs Market Size Forecast by Region (2026-2033) & (M USD)
Table 151. South America Influenza Drugs Sales Forecast by Country (2026-2033) & (K MT)
Table 152. South America Influenza Drugs Market Size Forecast by Country (2026-2033) & (M USD)
Table 153. Middle East and Africa Influenza Drugs Sales Forecast by Country (2026-2033) & (Units)
Table 154. Middle East and Africa Influenza Drugs Market Size Forecast by Country (2026-2033) & (M USD)
Table 155. Global Influenza Drugs Sales Forecast by Type (2026-2033) & (K MT)
Table 156. Global Influenza Drugs Market Size Forecast by Type (2026-2033) & (M USD)
Table 157. Global Influenza Drugs Price Forecast by Type (2026-2033) & (USD/MT)
Table 158. Global Influenza Drugs Sales (K MT) Forecast by Application (2026-2033)
Table 159. Global Influenza Drugs Market Size Forecast by Application (2026-2033) & (M USD)
List of Figures
Figure 1. Product Picture of Influenza Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Influenza Drugs Market Size (M USD), 2024-2033
Figure 5. Global Influenza Drugs Market Size (M USD) (2020-2033)
Figure 6. Global Influenza Drugs Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Influenza Drugs Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Influenza Drugs Product Life Cycle
Figure 13. Influenza Drugs Sales Share by Manufacturers in 2024
Figure 14. Global Influenza Drugs Revenue Share by Manufacturers in 2024
Figure 15. Influenza Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Influenza Drugs Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Influenza Drugs Revenue in 2024
Figure 18. Industry Chain Map of Influenza Drugs
Figure 19. Global Influenza Drugs Market PEST Analysis
Figure 20. Global Influenza Drugs Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Influenza Drugs Market Share by Type
Figure 27. Sales Market Share of Influenza Drugs by Type (2020-2025)
Figure 28. Sales Market Share of Influenza Drugs by Type in 2024
Figure 29. Market Size Share of Influenza Drugs by Type (2020-2025)
Figure 30. Market Size Share of Influenza Drugs by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Influenza Drugs Market Share by Application
Figure 33. Global Influenza Drugs Sales Market Share by Application (2020-2025)
Figure 34. Global Influenza Drugs Sales Market Share by Application in 2024
Figure 35. Global Influenza Drugs Market Share by Application (2020-2025)
Figure 36. Global Influenza Drugs Market Share by Application in 2024
Figure 37. Global Influenza Drugs Sales Growth Rate by Application (2020-2025)
Figure 38. Global Influenza Drugs Sales Market Share by Region (2020-2025)
Figure 39. Global Influenza Drugs Market Size Market Share by Region (2020-2025)
Figure 40. North America Influenza Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Influenza Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Influenza Drugs Sales Market Share by Country in 2024
Figure 43. North America Influenza Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Influenza Drugs Market Size Market Share by Country in 2024
Figure 45. U.S. Influenza Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Influenza Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Influenza Drugs Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Influenza Drugs Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Influenza Drugs Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Influenza Drugs Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Influenza Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Influenza Drugs Sales Market Share by Country in 2024
Figure 53. Europe Influenza Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Influenza Drugs Market Size Market Share by Country in 2024
Figure 55. Germany Influenza Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Influenza Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Influenza Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Influenza Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Influenza Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Influenza Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Influenza Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Influenza Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Influenza Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Influenza Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Influenza Drugs Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Influenza Drugs Sales Market Share by Region in 2024
Figure 67. Asia Pacific Influenza Drugs Market Size Market Share by Region in 2024
Figure 68. China Influenza Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Influenza Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Influenza Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Influenza Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Influenza Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Influenza Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Influenza Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Influenza Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Influenza Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Influenza Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Influenza Drugs Sales and Growth Rate (K MT)
Figure 79. South America Influenza Drugs Sales Market Share by Country in 2024
Figure 80. South America Influenza Drugs Market Size and Growth Rate (M USD)
Figure 81. South America Influenza Drugs Market Size Market Share by Country in 2024
Figure 82. Brazil Influenza Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Influenza Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Influenza Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Influenza Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Influenza Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Influenza Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Influenza Drugs Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Influenza Drugs Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Influenza Drugs Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Influenza Drugs Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Influenza Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Influenza Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Influenza Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Influenza Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Influenza Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Influenza Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Influenza Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Influenza Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Influenza Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Influenza Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Influenza Drugs Production Market Share by Region (2020-2025)
Figure 103. North America Influenza Drugs Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Influenza Drugs Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Influenza Drugs Production (K MT) Growth Rate (2020-2025)
Figure 106. China Influenza Drugs Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Influenza Drugs Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Influenza Drugs Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Influenza Drugs Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Influenza Drugs Market Share Forecast by Type (2026-2033)
Figure 111. Global Influenza Drugs Sales Forecast by Application (2026-2033)
Figure 112. Global Influenza Drugs Market Share Forecast by Application (2026-2033)